Neurodegenerative Diseases  >>  levodopa/carbidopa high dose (ND0612H)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
levodopa/carbidopa high dose (ND0612H) / Mitsubishi Tanabe
NCT01486628: Study of Subcutaneous Continuous Administration of Levodopa/Carbidopa Solution (ND0612) in Healthy Volunteers

Completed
1
36
RoW
ND0612, Placebo
NeuroDerm Ltd.
Parkinson's Disease
11/12
06/13
NCT01725802: A Safety, Tolerability, and Plasma Concentration Study of Levodopa/Carbidopa Subcutaneous Solution (ND0612) in Parkinson's Disease (PD) Patients

Completed
1
8
RoW
Levodopa/carbidopa solution for SC administration, ND0612, Placebo, Saline
NeuroDerm Ltd.
Parkinson's Disease
02/13
02/13

Download Options